*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Predictors and Prevalence of Proton Pump Inhibitor (PPI) Prescribing in Acute Coronary Syndrome (ACS)

Author: , WARDATI MAZLAN-KEPLI, LAI WAN MAE, ABDUL MUIZZ ABDUL MALEK, CHIA CHUN HOU, WINNIE NEOH TZE SHIN
Abstract: Background: Proton pump inhibitor (PPI) is recommended for patients on dual antiplatelet (DAPT) therapy with a history of prior gastrointestinal bleeding and those with multiple risk factors for GI bleeding. Several studies revealed that a large proportion of patients had no evidence-based indication for using PPI. However, there is a research gap in PPI prescribing among acute coronary syndrome (ACS) patients in Malaysia. This study aimed to determine the prevalence of PPI prescribing among ACS patients in Hospital Serdang and the predictors of PPI prescribing in this population. Results: Out of 467 patients (77.5 % male; mean age 57.0 (12.5) years), 36.4% (n=170) were prescribed with PPI during hospitalization. Of the 436 patients (77.1% male; mean age 56.7 (12.5) years) who were successfully discharged, 37.8% (n=165) were prescribed with PPI at discharge. Predictors of PPI during hospitalization and at discharge were similar including types of ACS in relation to unstable angina i.e. ST-elevation myocardial infarction (MI), low hemoglobin during admission and medicated with PPI before admission. On the other hand, concomitant anticoagulant, antiplatelet and DAPT were not predictors of PPI during hospitalization and at discharge. Conclusion: The prescribing of PPI during hospitalization and at discharge following ACS is modest, although it increased based on the type of MI, low hemoglobin during admission and whether patient was previously prescribed with PPI. We suggest larger studies to identify bleeding risks, and to explore practitioners’ awareness on PPI prescribing to optimize PPI prescriptions in future.
Keyword: proton pump inhibitors, acute coronary syndrome, predictors, discharge.
DOI: https://doi.org/10.31838/ijpr/2021.13.02.404
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free